1.	Sequential Vaccinations in Prostate Cancer Patients Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: 030176, 03-C-0176, NCI-03-C-0176, NCI-5911, 5911, NCT00062153, NCT00060528
2.	Phase I Study of Recombinant Fowlpox-CEA-TRICOM Vaccine With or Without Sargramostim (GM-CSF) or Recombinant Fowlpox-GM-CSF in Patients With Advanced or Metastatic CEA-Expressing Adenocarcinomas Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: FCCC-01016, NCI-1133, NCT00028496, 1133
3.	Phase I Pilot Study of Vaccine Therapy Comprising Priming Vaccinations of Vaccinia-PSA-TRICOM and Recombinant Fowlpox GM-CSF (rF-GM-CSF) Followed By Boosting Vaccinations of Fowlpox-PSA-TRICOM With or Without rF-GM-CSF in Patients With Progressive or Locally Recurrent Prostate Cancer Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-05-C-0017, NCI-6066, 6066, NCT00098449
4.	Pilot Study of Vaccinia-CEA-TRICOM Vaccine, Fowlpox-CEA-TRICOM Vaccine, Recombinant Fowlpox GM-CSF Vaccine, and Radiotherapy in Patients With Carcinoembryonic Antigen-Positive Solid Tumors Metastatic to the Liver Phase: No phase specified Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-04-C-0167, 6368, NCI-6368, NCT00085241
5.	Pilot Study of Vaccinia-CEA-TRICOM Vaccine, Fowlpox-CEA-TRICOM Vaccine, and Recombinant Fowlpox GM-CSF Vaccine With Paclitaxel, Carboplatin, and Radiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Phase: No phase specified Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-04-C-0252, NCI-6439, 6439, NCT00091039